Modeling and Simulation - PK/PD Archives | Page 11 of 41 | Certara

Blog

Application of PK/PD Modeling and Simulation in Drug Discovery and Development in China

By Yuancheng Chen, Research Associate of Phase 1 Unit, Huashan Hospital, Fudan University, and visiting…

CertaraAugust 7, 2020

Brochure

Phoenix PK/PD Platform

CertaraJune 22, 2020

Fact Sheet

Phoenix WinNonlin

CertaraJune 22, 2020

Fact Sheet

Certara Integral Data Repository

CertaraJune 22, 2020

Poster

Visualization of Complex Trial Data in Non-Linear Mixed-Effect Analyses With Covariates

CertaraJanuary 17, 2020

Publication

Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110

CertaraJanuary 17, 2020

On-Demand Webinar

How to Perform IVIVC for Delayed Release Drug Formulations

This webinar showed how to use a time correction factor to establish a meaningful IVIVC…

CertaraAugust 20, 2019

Poster

Population Pharmacokinetics of Piperacillin-Tazobactam Extended Infusions in Paediatric Population

CertaraJune 24, 2019

Poster

Pharmacodynamics of rituximab on B cells in paediatric post-HSCT patients with EBV

CertaraJune 24, 2019

White Paper

Optimize Immuno-oncology Drug Discovery and Development Using QSP

A Quantitative Systems Pharmacology (QSP) approach for developing combination immune-oncology therapies can be used to…

CertaraJune 19, 2019

© 2025 Certara. All Rights Reserved. | Legal | Privacy policy